Last 15,000 KRW
Change Today -50.00 / -0.33%
Volume 23.9K
003220 On Other Exchanges
Symbol
Exchange
Korea SE
As of 1:21 AM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for daewon pharmaceutical co ltd (003220)

Year over year, Daewon Pharmaceutical Co. Ltd. has been able to grow revenues from $125.6M USD to $144.5M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 48.34% to 47.27%. This was a driver that led to a bottom line growth from $8.7M USD to $11.2M USD.
View Income Statement In South Korean Won
Currency in
Millions of US Dollars
As of:Dec 31
2010
Press
Release

USD
Dec 31
2011
USD
Dec 31
2012
USD
Dec 31
2013
USD
4 Year
Trend
Revenues131.6126.3125.6144.5
Other Revenues--0.0----
TOTAL REVENUES131.6126.3125.6144.5
Cost of Goods Sold--57.160.768.3
GROSS PROFIT131.669.264.976.2
Selling General & Admin Expenses, Total--48.046.555.0
R&D Expenses--5.24.45.2
Depreciation & Amortization, Total--0.70.80.9
Other Operating Expenses113.33.21.00.9
OTHER OPERATING EXPENSES, TOTAL113.357.052.662.0
OPERATING INCOME18.212.212.214.1
Interest Expense---0.3-0.2-0.1
Interest and Investment Income--0.30.60.7
NET INTEREST EXPENSE--0.10.40.6
Currency Exchange Gains (Loss)--0.1-0.10.1
Other Non-Operating Income (Expenses)0.1-0.20.20.3
EBT, EXCLUDING UNUSUAL ITEMS18.412.112.815.1
Gain (Loss) on Sale of Investments---0.1-0.7-0.1
Gain (Loss) on Sale of Assets---0.10.0-0.2
Other Unusual Items, Total---0.5-0.7-0.7
EBT, INCLUDING UNUSUAL ITEMS18.411.411.414.2
Income Tax Expense7.63.02.53.1
Minority Interest in Earnings--0.2-0.10.1
Earnings from Continuing Operations10.88.48.911.1
NET INCOME10.88.68.711.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS10.88.68.711.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS10.88.68.711.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003220:KS 15,000.00 KRW -50.00

003220 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 003220.
View Industry Companies
 

Industry Analysis

003220

Industry Average

Valuation 003220 Industry Range
Price/Earnings 17.7x
Price/Sales 1.3x
Price/Book 1.8x
Price/Cash Flow 17.4x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEWON PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.